SWM
IBIO icon

SHP Wealth Management’s iBio IBIO Stock Holding History

SHP Wealth Management’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$105 Hold
60
– – ﹤0.01% 1937
2026
Q1 		$114 Hold
60
– – ﹤0.01% 1775
2025
Q4 		$116 Buy
+60
New +$82 ﹤0.01% 1495

Other funds holding IBIO

AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

SHP Wealth Management's IBIO Position: Q2 2026 in Review

SHP Wealth Management held its iBio (IBIO) position steady in Q2 2026 at 60 shares worth $105. The position accounts for ﹤0.01% of the portfolio, ranked #1937.

SHP Wealth Management first reported a position in IBIO in Q4 2025 and has held it in 3 quarters since. The position peaked at $116 in Q4 2025. 55 funds tracked by Wall St. Rank hold IBIO as of Q2 2026.

  • SHP Wealth Management held 60 shares of iBio worth $105 as of Q2 2026.
  • SHP Wealth Management left its iBio share count unchanged in Q2 2026.
  • iBio made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #1937 holding.
  • SHP Wealth Management first reported a position in iBio in Q4 2025 and has held it in 3 quarters since.
  • SHP Wealth Management's iBio position peaked at $116 in Q4 2025.
  • 55 funds tracked by Wall St. Rank held iBio as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.